Pg 22 | Cover Story

Cutting-Edge Pharma Machinery: A New Era Begins Exploring the Technologies Redefining Pharmaceutical Manufacturing

Pg 22 | Cover Story

Cutting-Edge Pharma Machinery: A New Era Begins Exploring the Technologies Redefining Pharmaceutical Manufacturing

12 Grids

Cutting-Edge Pharma Machinery: A New Era Begins

FEATURING

    • Get Insights from the News Around the World.

    • Cover Story | Cutting-Edge Pharma Machinery: A New Era Begins

    • "In Talks With Leadership" featuring some of the biggest names in the Pharma Industry.

    • It's HER Saga: Featuring an interview with Dr. Pragya Yadav covering her inspiring contributions in several vaccine trials at ICMR.

    • Expertly Curated Articles by our Contributors.

    • Pharma Now on the Field: Covering Insights from some of the biggest pharmaceutical events in the industry.

Read Now

Section Overview

News Around the World

12 Grids

Alembic Pharmaceuticals Receives US FDA Final Approval For Lamotrigine Extended-Release Tablets USP

Alembic gets US FDA approval for Lamotrigine Extended-Release Tablets to treat seizures in patients.

MAGAZINE ARTICLE by Simantini Singh Deo

12 Grids

Globus Medical Introduces Next-Gen Orthopedic Trauma Solutions

Globus Medical expands its orthopedic trauma lineup in 2024, launching new products.

MAGAZINE ARTICLE by Simantini Singh Deo

12 Grids

Angelini Pharma Secures Global Rights To Brain Health Treatment With Cureverse Deal

Angelini Pharma partners with Cureverse to develop CV-01, a promising brain health treatment in trials.

MAGAZINE ARTICLE by Simantini Singh Deo

12 Grids

Lilly To Drive Drug Innovation With New $4.5 Billion Medicine Foundry

Eli Lilly invests $4.5 billion to create the Lilly Medicine Foundry in Indiana, enhancing drug manufacturing and development.

MAGAZINE ARTICLE by Simantini Singh Deo

12 Grids

Merck’s KEYNOTE-689: Major Success in Cancer Treatment

KEYTRUDA improves event-free survival in advanced head and neck cancer, showing significant results.

MAGAZINE ARTICLE by Mrudula Kulkarni

Ad
Advertisement
News Letter

Subscribe to our Newsletter!

Be the first to get exclusive offers and the latest news

Ad
Advertisement
Ad
Advertisement
Ad
Advertisement
Ad
Advertisement